Hemi-Gland Cryoablation for Prostate Cancer at UCLA
NCT: NCT03503643 · COMPLETED
Brief Summary
This is a prospective data collection of men who are electing to undergo prostate hemi-gland cryoablation. The purpose of this observational research study is to investigate the localized treatment of prostate cancer using hemi-gland cryoablation. UCLA patients undergoing hemi-gland cryoablation are a unique cohort compared to prior research because all patients at UCLA have had a pre-treatment multi-parametric MRI and Ultrasound fusion targeted biopsy; they will be followed in a similar fashion. This results in more precise assessment of a target region of cancer for ablation which may, in turn, result in improved clinical outcomes.
Frequently Asked Questions
What is Hemi-Gland Cryoablation for Prostate Cancer at UCLA?
Hemi-Gland Cryoablation for Prostate Cancer at UCLA is a clinical trial registered under NCT03503643. Current status: COMPLETED.
What is the status of NCT03503643?
The current status of NCT03503643 (Hemi-Gland Cryoablation for Prostate Cancer at UCLA) is: COMPLETED.
When did Hemi-Gland Cryoablation for Prostate Cancer at UCLA start?
Hemi-Gland Cryoablation for Prostate Cancer at UCLA started on 2017-09-14.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.